Web21 hours ago · ALBANY, N.Y., April 13, 2024 /PRNewswire/ -- YDS Pharmatech, a computational drug discovery company specializing in induced proximity, today announced the appointment of Dr. Robert Sullivan as Head of Medicinal Chemistry. With over 20 years of experience in the field, Dr. Sullivan possesses expertise in small molecules, … WebAug 18, 2024 · Implementación de laboratorio farmacéutico GMP para la producción de vacunas para uso humano, destinadas a estudios científico clínicos fase I y/o II, adjudicado a BIOTHERVAX , proyecto liderado por el Dr. Alexis Kalergis. Ambos proyectos han obtenido el monto total del aporte, correspondiente a $120.000.000.
Cinco proyectos apoyados por FCUC se adjudicaron fondos que …
WebApr 5, 2024 · Our pipeline of bifunctional degraders includes the first-ever degraders of SOS1 for pan-KRAS mutant cancers, CDK4/6 for solid tumors and PDE4 for … WebMay 20, 2024 · Biotheryx is a clinical stage biopharmaceutical company discovering and developing a portfolio of innovative small molecule targeted protein degraders (TPDs) in … sonix golf target
BioThrax (Anthrax Vaccine Adsorbed) Emergent BioSolutions
Web2 days ago · Incyte and Biotheryx have entered into a research collaboration and licensing agreement to discover and develop protein degraders for ‘historically undruggable’ oncology targets. The partnership will see Biotheryx use its PRODEGY platform to identify and initially develop molecular glue degraders, which are designed to leverage the body’s ... WebIn an open-label safety study of 15,907 doses of BioThrax administered by the subcutaneous route to approximately 7,000 textile employees, laboratory workers and … WebApr 12, 2024 · the daughter of Nina Gore and Hugh D. Auchincloss. Hugh Auchincloss, Jr., was born to Hugh Auchincloss, Sr. (1915−1998), and Katharine Lawrence Bundy. small low lying island